BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1598464)

  • 1. [The effect of low-dose acetylsalicylic acid on platelet aggregation parameters in vitro].
    Cardona M; Escolar G; Roig E; Bastida E; Ordinas A; Sanz G
    Rev Esp Cardiol; 1992 Apr; 45(4):264-9. PubMed ID: 1598464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL; Malinin AI; Pokov AN; Hanley DF
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new cyclooxygenase-2 inhibitor, rofecoxib (VIOXX), did not alter the antiplatelet effects of low-dose aspirin in healthy volunteers.
    Greenberg HE; Gottesdiener K; Huntington M; Wong P; Larson P; Wildonger L; Gillen L; Dorval E; Waldman SA
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1509-15. PubMed ID: 11185674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superior efficacy of clopidogrel plus acetylsalicylic acid compared with extended-release dipyridamole plus acetylsalicylic acid in preventing arterial thrombogenesis in healthy volunteers.
    Cadroy Y; Thalamas C; Sakariassen K; Boneu B
    Thromb Res; 2005; 116(4):293-300. PubMed ID: 16038713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Low doses of acetylsalicylic acid effectively inhibits thrombocyte aggregation after ischemic stroke].
    Oláh L; Misz M; Bereczki D; Fekete I; Bordánné JE; Takács EI
    Orv Hetil; 1996 Mar; 137(9):455-9. PubMed ID: 8714038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pilot trial of the effects of low-dose acetylsalicylic acid on platelet thromboxane B2 production.
    Janssen PL; Akkerman JW; Hollman PC; van Staveren WA; Zwaginga JJ; Katan MB
    Eur J Clin Nutr; 1995 May; 49(5):365-70. PubMed ID: 7664723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of chronic proliferative glomerulonephritis using acetylsalicylic acid and dipyridamole].
    Knotková V; Petrů I; Nĕmecek K; Cieslar P; Pelèska J; Jáchymová M; Pick P; Tomasy M
    Cas Lek Cesk; 1989 Jun; 128(26):814-8. PubMed ID: 2507156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin?
    Markuszewski L; Rosiak M; Golanski J; Rysz J; Spychalska M; Watala C
    Basic Clin Pharmacol Toxicol; 2006 May; 98(5):503-9. PubMed ID: 16635110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid platelet inhibition after a single capsule of Aggrenox: challenging a conventional full-dose aspirin antiplatelet advantage?
    Serebruany VL; Malinin AI; Sane DC
    Am J Hematol; 2003 Apr; 72(4):280-1. PubMed ID: 12666142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-platelet effects of 100 mg alternate day oral aspirin: a randomized, double-blind, placebo-controlled trial of regular and enteric coated formulations in men and women.
    Ridker PM; Hennekens CH; Tofler GH; Lipinska I; Buring JE
    J Cardiovasc Risk; 1996 Apr; 3(2):209-12. PubMed ID: 8836865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet activity and aspirin efficacy after off-pump compared with on-pump coronary artery bypass surgery: results from the prospective randomized trial PRAGUE 11-Coronary Artery Bypass and REactivity of Thrombocytes (CABARET).
    Bednar F; Osmancik P; Vanek T; Mocikova H; Jares M; Straka Z; Widimsky P
    J Thorac Cardiovasc Surg; 2008 Oct; 136(4):1054-60. PubMed ID: 18954649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease.
    Renda G; Tacconelli S; Capone ML; Sacchetta D; Santarelli F; Sciulli MG; Zimarino M; Grana M; D'Amelio E; Zurro M; Price TS; Patrono C; De Caterina R; Patrignani P
    Clin Pharmacol Ther; 2006 Sep; 80(3):264-74. PubMed ID: 16952493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dipyridamole potentiates the inhibition of platelet aggregation by aspirin (in human platelet rich plasma and whole blood).
    Violi F; Praticò D; Iuliano L; Balsano F
    J Lipid Mediat; 1991; 4(1):61-7. PubMed ID: 1909906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of aspirin and dipyridamole on platelet function, hematology, and blood chemistry of saturation divers.
    Philp RB; Bennett PB; Andersen JC; Fields GN; McIntyre BA; Francey I; Briner W
    Undersea Biomed Res; 1979 Jun; 6(2):127-46. PubMed ID: 531993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose- and time-dependent antiplatelet effects of aspirin.
    Perneby C; Wallén NH; Rooney C; Fitzgerald D; Hjemdahl P
    Thromb Haemost; 2006 Apr; 95(4):652-8. PubMed ID: 16601836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Blood platelet function in patients with coronary disease after administration of acetylsalicylic acid and dipyridamole].
    Olszańska-Skorek T; Mazurowa A; Pełczyńska I; Chojnowski K; Hołub A; Drzewoski J
    Pol Tyg Lek; 1983 Feb; 38(9):269-72. PubMed ID: 6866846
    [No Abstract]   [Full Text] [Related]  

  • 17. Dipyridamole inhibits platelet aggregation in whole blood.
    Gresele P; Zoja C; Deckmyn H; Arnout J; Vermylen J; Verstraete M
    Thromb Haemost; 1983 Dec; 50(4):852-6. PubMed ID: 6665766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of platelet aggregation after intake of acetylsalicylic acid detected by a platelet function analyzer (PFA-100).
    Feuring M; Haseroth K; Janson CP; Falkenstein E; Schmidt BM; Wehling M
    Int J Clin Pharmacol Ther; 1999 Dec; 37(12):584-8. PubMed ID: 10599950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetylsalicylic acid and dipyridamole improve the early patency of aorta-coronary bypass grafts. A double-blind, placebo-controlled, randomized trial.
    Rajah SM; Salter MC; Donaldson DR; Subba Rao R; Boyle RM; Partridge JB; Watson DA
    J Thorac Cardiovasc Surg; 1985 Sep; 90(3):373-7. PubMed ID: 3897722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indobufen versus dipyridamole plus aspirin in the treatment of patients with peripheral atherosclerotic disease.
    Fabris F; Steffan A; Randi ML; Avruscio GP; Cordiano I; Girolami A
    J Med; 1992; 23(2):81-92. PubMed ID: 1512524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.